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Until recently, the Cook Zenith aortic endograft (Cook Medical Inc, Bloomington, Ind) was the only device used for
physician-modiﬁed fenestration because its constraining wire allowed physicians to reconstrain the device after modiﬁ-
cations. Although the Cook Zenith fenestrated endograft has been approved by the Food and Drug Administration, it is
currently not available in the majority of the hospitals and is not applicable to the patients who need urgent or emergent
aneurysm repair. With the redesign of the Gore C3 delivery system, the Gore Excluder aortic stent graft (W. L. Gore &
Associates, Inc, Flagstaff, Ariz) can now also be reconstrained, which makes it suitable for physician-modiﬁed fenestra-
tion. We describe the technique for modiﬁcation and implantation of the Gore Excluder aortic stent graft in a patient
requiring 2-vessel bilateral renal artery fenestration. This application provides an additional option for treatment of
patients with abdominal aortic aneurysms who are anatomically unsuitable for conventional endovascular aneurysm
repair and are at high risk for open repair. (J Vasc Surg 2014;59:1739-43.)Endovascular repair is increasingly becoming the pre-
ferred approach for repair of infrarenal abdominal aortic
aneurysm.1 However, some patients do not meet criteria
for conventional endovascular repair because of unfavorable
neck anatomy or inadequate proximal seal zone.2 Patients
with low and moderate risk proﬁles as deﬁned by their med-
ical comorbidities may tolerate open repair, but high-risk pa-
tients have signiﬁcantly increased mortality rates, which
range from 2%-14%.3 Debranching of the visceral aorta
with subsequent aortic stent grafting and placement of stent
grafts into the visceral branches alongside the main body
aortic endograft (“snorkel” or “chimney” techniques) are
used to decrease morbidity and mortality rates in high-risk
patients.4 Some specialty centers are using commercially pro-
duced branched or fenestrated aortic endografts.5,6the Division of Vascular and Endovascular Surgery, Louisiana State
niversity Health Sciences Center.
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and customization of grafts requires up to 6-8 weeks.7,8
The technique for physician modiﬁcation of stent grafts
with the use of commercially available Z stent grafts has
been described in detail previously.9 Reconstraining a stent
graft after deployment is the critical feature. The ability to
partially deploy and subsequently reconstrain the Gore C3
Excluder aortic stent graft (W. L. Gore & Associates, Inc,
Flagstaff, Ariz) has made this an attractive option for
physician-modiﬁed endovascular aneurysm repair.
CASE REPORT AND DEVICE MODIFICATION
The patient was a 66-year-oldmanwho had a 5.6-cm juxtarenal
abdominal aortic aneurysm. He was at high risk for open repair
because of severe chronic obstructive pulmonary disease and coro-
nary artery disease. Food andDrugAdministration (FDA)-approved
Zenith fenestrated (Cook Medical Inc, Bloomington, Ind) endo-
vascular device was not available at our institution. The risks and
beneﬁts of different treatment options, including open aneurysm
repair, conservative medical management, and endovascular repair
with physician-modiﬁed stent grafts, were discussed with the
patient; he fully understood that fenestrated endovascular aneurysm
repair with physician-modiﬁed stent grafts was off-label use and
consented to proceed with the procedure. This case was a compas-
sionate use without investigational device exemptions. Follow-up
computed tomographic angiography (CTA) at 1 month and
aortography at 3 months, while having carotid stenting for symp-
tomatic carotid stenosis, showed no evidence of endoleak or renal
artery stenosis. Follow-up with CTA every 6 months is planned.1739
Fig 1. Reconstruction of preoperative computed tomographic angiography (CTA) and localization of branch vessels
by means of clock-face orientation.
Fig 2. Position and location of fenestrations are measured and
marked on the main body graft according to preoperative plan-
ning. The stent graft can be rotated a few degrees clockwise or
counterclockwise to ﬁnd a larger space for fenestration between
stent struts.
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of the landing zone and size of the branch oriﬁces were identiﬁed
by means of centerline analysis on CTA. Axial images were used to
identify the position of the branch vessels by use of clock-face
orientation (Fig 1).
Endograft modiﬁcation was performed under strict sterile
conditions on a back table. The valve of a 20F DrySeal sheath
(W. L. Gore & Associates, Inc) was cut off. The sheath was cut
to the size corresponding to the length of the main body endograft
and then loaded onto the delivery system to reconstrain the device
after modiﬁcation. A Gore C3 Excluder aortic endograft was
unsheathed until the contralateral gate was released, leaving the
ipsilateral limb constrained. The locations for the fenestrations
were pre-marked on the body of the stent graft by use of the mea-
surements obtained from the centerline analysis on CTA (Fig 2).
The fenestrations were made with a No. 11 blade and then were
reinforced with the use of a wire from an EnSnare (Merit Medical,South Jordan, Utah), which was sutured circumferentially with
running 5-0 Prolene (Fig 3).
The fenestrations were then precannulated with V-14 wires.
Two V-14 wires were inserted into the main body through contra-
lateral gate and pulled out from the fenestrations separately. The
distal ends of the wires were then passed through the 20F DrySeal
sheath, which was placed onto the shaft of the delivery system
before deployment for modiﬁcation. The stent graft was then re-
loaded retrogradely into the DrySeal sheath (Fig 4). Umbilical
tape and 0-0 silk ties were used to collapse the stents for reloading.
DEVICE IMPLANTATION
The right femoral access was used for introduction of
the main body and the left femoral access for placement
of the contralateral limb. A 22F DrySeal sheath was intro-
duced. The reconstrained main body was then introduced
through the femoral sheath. A peel-away sheath was used
to protect the V-14 wires from the sheath valve during
insertion.
The top of the main body was positioned just inferior
to superior mesenteric artery (SMA) according to the
lateral aortogram. The precannulated V-14 wires were
used to selectively cannulate both renal arteries. This was
conﬁrmed by means of angiography, and the V-14 wires
were then exchanged for Amplatz wires with a 1-cm ﬂex-
ible tip (Boston Scientiﬁc, Boston, Mass). After access of
both renal arteries was achieved, the aortic endograft was
deployed and the proximal seal zone was fully expanded
with a Q50 balloon (W. L. Gore & Associates, Inc)
(Fig 5). Two iCast covered stents (Atrium Medical,
Hudson, NH) were deployed into both renal arteries and
ﬂared proximally with an 8-mm angioplasty balloon
(Fig 6). The contralateral gate was then cannulated, and
Fig 3. Fenestrations are reinforced by suturing EnSnare wire
(Merit Medical, South Jordan, Utah) circumferentially with 5-
0 Prolene (A and B). Fenestrations are then precannulated
through the contralateral gate with V-14 wires (C).
Fig 4. Endograft is reconstrained and reloaded into previously cut
and loaded DrySeal sheath (W. L. Gore & Associates, Inc, Flagstaff,
Ariz). Endograft stents are further collapsed with the use of um-
bilical tape. When the endograft is fully reloaded, the precannulated
V-14 wires extend beyond the tip of the reloaded device.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 6 Coulter et al 1741the contralateral limb was deployed in the standard fashion.
The completion angiogram demonstrated patency of the
SMA, both renal arteries, and no evidence of any endoleak.
This was conﬁrmed on follow-up CTA 1 month after the
procedure (Fig 7).
DISCUSSION AND TECHNICAL POINTS
The technique of C3 Excluder fenestration was origi-
nally described and presented by Dr Gustavo Paludetto
from Brazil at the Vascular Interventional Advances
(VIVA), 2012, in Las Vegas, Nevada. According toPubMed search, no case has been published previously.
The steps for Gore C3 Excluder modiﬁcation are summa-
rized in the Table.
The fenestrated Gore C3 Excluder stent graft was pre-
tested in vitro with the use of a demo device. To prevent
tearing of expanded polytetraﬂuoroethylene (ePTFE)
membrane, we sutured a piece of EnSnare wire around
the edges to reinforce the fenestrations and make them
visible under ﬂuoroscopy. Long-term follow-up is needed
for durability evaluation.
Reformatting of the preoperative CTA that allows for
centerline analysis is mandatory to ensure accurate posi-
tioning of the fenestrations. The sealing zone of the aneu-
rysm should have a length of at least 15 mm above the
highest renal artery and must be free of extensive
calciﬁcation.
Additionally, in the event that brachial artery access is
required (eg, for patients with challenging “downward-
angled” branch vessels), a 7F sheath is usually required as
opposed to the 12F sheath described in modiﬁcation of
the Zenith endograft.7
Device modiﬁcation. The presence of stent struts in
the middle of the fenestrations may interfere with place-
ment of covered stents into the renal or visceral vessels.
To minimize the need to remove stent struts, all fenestra-
tions should be marked on the main body of the endograft
before making any cuts in the ePTFE. The positions of the
fenestrations can be rotated a few degrees clockwise or
counterclockwise synchronously until the positions are
found in which the minimum number of stent struts are
removed. The fenestrations might not be perfectly round,
but it should not impede the accurate placement because
the fenestrations are prewired with V-14, and this facilitates
renal artery cannulation. Care must be taken not to incor-
porate the reconstraining suture for the aortic stent graft
when suturing the snare wire. The use of a Freer elevator
to collapse the anchors is helpful to facilitate complete
reloading.
The relatively short main body length of C3 Excluder
devices is a concern for maintaining an adequate landing
zone. The main body length is 4 cm in the 23-, 26-, and
28-mm devices; 5 cm in the 31-mm device; and 6 cm in
the 35-mm device. In the majority of patients, the longitu-
dinal distance between bilateral renal arteries is <2 cm.
A 4-cm main body allows physicians to make fenestrations
within 2 cm above the ﬂow divider and reserve at least 2 cm
above the fenestrations as proximal landing zone. Howev-
er, if the longitudinal distance between the renal arteries is
>2 cm or SMA fenestration is needed for suprarenal aneu-
rysm, the working length of a 4-cm main body may not be
long enough, unless 31-mm or 35-mm devices with longer
main body are used.
Device implantation. In this case, the positions of the
renal arteries were identiﬁed by means of the clock-face
orientation technique. Arc lengths were not calculated
because the patient’s abdominal aorta at the level of the
renal arteries was not dilated and bilateral renal arteries
were in the straight lateral direction. In general, arc length
Fig 5. With the bilateral renal artery wire access secured, the main body of the endograft is deployed. The proximal
endograft can be reconstrained to reposition the main body if needed. When the position of the endograft is correct,
the proximal seal zone was expanded with a Q50 balloon (W. L. Gore & Associates, Inc, Flagstaff, Ariz).
Fig 6. Stent grafts are deployed in the renal arteries (A). After
deployment, the stent grafts are ﬂared within the main body aortic
endograft with the use of an 8-mm angioplasty balloon (B). Two
thirds of the branch stent grafts should be within the branch vessel,
with one third extending into the aortic endograft.
Fig 7. Follow-up computed tomographic angiography (CTA) at
1 month shows patency of superior mesenteric artery (SMA) and
bilateral renal arteries with no evidence of endoleak.
JOURNAL OF VASCULAR SURGERY
1742 Coulter et al June 2014calculation is recommended if the accuracy of renal artery
localization is concerned.
If the DrySeal sheath is not long enough, the ability
of reconstraining main body of the C3 Excluder deviceallows physicians to push the stent graft out of the sheath
partially deployed and advance it into the aorta above
renal arteries. Physicians can also fully open and partially
or completely reconstrain the main body to make adjust-
ments accommodating the fenestrations to renal arteries.
Table. Steps for physician modiﬁcation of Gore Excluder endograft with C3 delivery system
1. Preoperative planning with the use of three-dimensional reconstruction of CTA and centerline analysis.
2. DrySeal sheath preloaded onto delivery system. Endograft is partially deployed.
3. Fenestrations are made by sharply incising the ePTFE and reinforced by circumferentially suturing a cut EnSnare wire.
4. Fenestrations are precannulated with V-14 wires through the contralateral gate.
5. Endograft is reconstrained and loaded into cut DrySeal sheath.
CTA, Computed tomographic angiography; ePTFE, expanded polytetraﬂuoroethylene.
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must be deployed and ballooned before placement of
the branch-covered stent to prevent crushing the portion
of the branch-covered stent extending into the main
endograft.
Although the Cook Zenith fenestrated endograft has
been approved by FDA, it is not applicable to the patients
who need urgent or emergent aneurysm repair. On the ba-
sis of the advisory statement on clinical use of modiﬁed
aortic endografts from the Society for Vascular Surgery,10
Gore C3 Excluder fenestration may be performed as an
alternative procedure for compassionate use in high-risk
patients and in urgent or emergent cases when FDA-
approved fenestrated endografts are not available. How-
ever, we would like to make it clear that this technique is
not FDA-approved. Although each fenestration is rein-
forced with a piece of wire and 5-0 Prolene sutures, endo-
leak may develop if degeneration of the fenestrations in
ePTFE graft occurs after long-term hemodynamic stress.
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